Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Greenberg, Richard N ^a   Hurley, Maria Yadira ^a   Dinh, Dinh V ^a   Mraz, Serena ^a   Vera, Javier Gomez ^a   Von Bredow, Dorothea ^a   Von Krempelhuber, Alfred ^a   Roesch, Siegfried ^a   Virgin, Garth ^a   Arndtz Wiedemann, Nathaly ^a   Meyer, Thomas Peter ^a   Schmidt, Darja ^a   Nichols, Richard ^a   Young, Philip ^a   Chaplin, Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 84953213735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142802     Document Type: Erratum

References (1)

1. Greenberg RN, Hurley Y, Dinh DV, Mraz S, Vera JG, von Bredow D, et al. (2015) A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis. PLoS ONE 10(10): e0138348. doi: 10.1371/journal.pone.0138348